Trial Profile
Mepolizumab Effectiveness in Patients With Severe Eosinophilic Asthma and Co-presence of Bronchiectasis
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 04 Jan 2024
Price :
$35
*
At a glance
- Drugs Mepolizumab (Primary)
- Indications Asthma; Bronchiectasis; Eosinophilia
- Focus Therapeutic Use
- 18 Jan 2022 New trial record